top of page

A paradigm shift in drug delivery systems

TissueGen's proprietary technology makes possible extended release formulations for drugs ranging from small molecules to temperature-sensitive biologics. Our patent-protected technology is particularly well suited to creating a new class of drug-eluting devices designed to orchestrate the body's own healing processes to significantly improve clinical outcomes after trauma or surgery.

ABOUT

biologics. Our patent-protected technology is particularly well suited to creating a new class
release formulations for drugs ranging from small molecules to temperature-sensitive
TissueGen's proprietary technology makes possible extended
of drug-eluting devices designed to orchestrate the body's own healing processes
 to significantly improve clinical outcomes after trauma or surgery. 
Dr. Kevin Nelson Founder of TissueGen

- Dr. Kevin Nelson, Founder and CSO

APPLICATIONS

New%2520Project%2520(2)%2520copy_edited_

A

D

V

A

N

C

E

D

DRUG

DELIVERY

TissueGen Nerve Regeneration

R

E

G

E

N

E

R

20

1 7

O

I

T

A

NERVE

N

TissueGen Tissue Engineering

E

N

G

I

N

E

E

20

1 7

G

N

I

R

TISSUE

ABOUT
APPLICATIONS
/ 0 3
/ 0 3
/ 0 3
bottom of page